1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Antiretroviral Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Multi-Class Drugs Combination 1.2.3 NRTI 1.2.4 NNRTI 1.2.5 Protease Inhibitors 1.2.6 Other 1.3 Market by Application 1.3.1 Global Antiretroviral Drug Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Pharmaceutical Companies 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Antiretroviral Drug Market Perspective (2016-2027) 2.2 Antiretroviral Drug Growth Trends by Regions 2.2.1 Antiretroviral Drug Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Antiretroviral Drug Historic Market Share by Regions (2016-2021) 2.2.3 Antiretroviral Drug Forecasted Market Size by Regions (2022-2027) 2.3 Antiretroviral Drug Industry Dynamic 2.3.1 Antiretroviral Drug Market Trends 2.3.2 Antiretroviral Drug Market Drivers 2.3.3 Antiretroviral Drug Market Challenges 2.3.4 Antiretroviral Drug Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Antiretroviral Drug Players by Revenue 3.1.1 Global Top Antiretroviral Drug Players by Revenue (2016-2021) 3.1.2 Global Antiretroviral Drug Revenue Market Share by Players (2016-2021) 3.2 Global Antiretroviral Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Antiretroviral Drug Revenue 3.4 Global Antiretroviral Drug Market Concentration Ratio 3.4.1 Global Antiretroviral Drug Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Antiretroviral Drug Revenue in 2020 3.5 Antiretroviral Drug Key Players Head office and Area Served 3.6 Key Players Antiretroviral Drug Product Solution and Service 3.7 Date of Enter into Antiretroviral Drug Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Antiretroviral Drug Breakdown Data by Type 4.1 Global Antiretroviral Drug Historic Market Size by Type (2016-2021) 4.2 Global Antiretroviral Drug Forecasted Market Size by Type (2022-2027) 5 Antiretroviral Drug Breakdown Data by Application 5.1 Global Antiretroviral Drug Historic Market Size by Application (2016-2021) 5.2 Global Antiretroviral Drug Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Antiretroviral Drug Market Size (2016-2027) 6.2 North America Antiretroviral Drug Market Size by Type 6.2.1 North America Antiretroviral Drug Market Size by Type (2016-2021) 6.2.2 North America Antiretroviral Drug Market Size by Type (2022-2027) 6.2.3 North America Antiretroviral Drug Market Size by Type (2016-2027) 6.3 North America Antiretroviral Drug Market Size by Application 6.3.1 North America Antiretroviral Drug Market Size by Application (2016-2021) 6.3.2 North America Antiretroviral Drug Market Size by Application (2022-2027) 6.3.3 North America Antiretroviral Drug Market Size by Application (2016-2027) 6.4 North America Antiretroviral Drug Market Size by Country 6.4.1 North America Antiretroviral Drug Market Size by Country (2016-2021) 6.4.2 North America Antiretroviral Drug Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Antiretroviral Drug Market Size (2016-2027) 7.2 Europe Antiretroviral Drug Market Size by Type 7.2.1 Europe Antiretroviral Drug Market Size by Type (2016-2021) 7.2.2 Europe Antiretroviral Drug Market Size by Type (2022-2027) 7.2.3 Europe Antiretroviral Drug Market Size by Type (2016-2027) 7.3 Europe Antiretroviral Drug Market Size by Application 7.3.1 Europe Antiretroviral Drug Market Size by Application (2016-2021) 7.3.2 Europe Antiretroviral Drug Market Size by Application (2022-2027) 7.3.3 Europe Antiretroviral Drug Market Size by Application (2016-2027) 7.4 Europe Antiretroviral Drug Market Size by Country 7.4.1 Europe Antiretroviral Drug Market Size by Country (2016-2021) 7.4.2 Europe Antiretroviral Drug Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Antiretroviral Drug Market Size (2016-2027) 8.2 Asia-Pacific Antiretroviral Drug Market Size by Type 8.2.1 Asia-Pacific Antiretroviral Drug Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Antiretroviral Drug Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Antiretroviral Drug Market Size by Type (2016-2027) 8.3 Asia-Pacific Antiretroviral Drug Market Size by Application 8.3.1 Asia-Pacific Antiretroviral Drug Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Antiretroviral Drug Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Antiretroviral Drug Market Size by Application (2016-2027) 8.4 Asia-Pacific Antiretroviral Drug Market Size by Region 8.4.1 Asia-Pacific Antiretroviral Drug Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Antiretroviral Drug Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Antiretroviral Drug Market Size (2016-2027) 9.2 Latin America Antiretroviral Drug Market Size by Type 9.2.1 Latin America Antiretroviral Drug Market Size by Type (2016-2021) 9.2.2 Latin America Antiretroviral Drug Market Size by Type (2022-2027) 9.2.3 Latin America Antiretroviral Drug Market Size by Type (2016-2027) 9.3 Latin America Antiretroviral Drug Market Size by Application 9.3.1 Latin America Antiretroviral Drug Market Size by Application (2016-2021) 9.3.2 Latin America Antiretroviral Drug Market Size by Application (2022-2027) 9.3.3 Latin America Antiretroviral Drug Market Size by Application (2016-2027) 9.4 Latin America Antiretroviral Drug Market Size by Country 9.4.1 Latin America Antiretroviral Drug Market Size by Country (2016-2021) 9.4.2 Latin America Antiretroviral Drug Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Antiretroviral Drug Market Size (2016-2027) 10.2 Middle East & Africa Antiretroviral Drug Market Size by Type 10.2.1 Middle East & Africa Antiretroviral Drug Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Antiretroviral Drug Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Antiretroviral Drug Market Size by Type (2016-2027) 10.3 Middle East & Africa Antiretroviral Drug Market Size by Application 10.3.1 Middle East & Africa Antiretroviral Drug Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Antiretroviral Drug Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Antiretroviral Drug Market Size by Application (2016-2027) 10.4 Middle East & Africa Antiretroviral Drug Market Size by Country 10.4.1 Middle East & Africa Antiretroviral Drug Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Antiretroviral Drug Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Gilead Sciences 11.1.1 Gilead Sciences Company Details 11.1.2 Gilead Sciences Business Overview 11.1.3 Gilead Sciences Antiretroviral Drug Introduction 11.1.4 Gilead Sciences Revenue in Antiretroviral Drug Business (2016-2021) 11.1.5 Gilead Sciences Recent Development 11.2 ViiV Healthcare 11.2.1 ViiV Healthcare Company Details 11.2.2 ViiV Healthcare Business Overview 11.2.3 ViiV Healthcare Antiretroviral Drug Introduction 11.2.4 ViiV Healthcare Revenue in Antiretroviral Drug Business (2016-2021) 11.2.5 ViiV Healthcare Recent Development 11.3 Bristol-Myer Squibb 11.3.1 Bristol-Myer Squibb Company Details 11.3.2 Bristol-Myer Squibb Business Overview 11.3.3 Bristol-Myer Squibb Antiretroviral Drug Introduction 11.3.4 Bristol-Myer Squibb Revenue in Antiretroviral Drug Business (2016-2021) 11.3.5 Bristol-Myer Squibb Recent Development 11.4 AbbVie 11.4.1 AbbVie Company Details 11.4.2 AbbVie Business Overview 11.4.3 AbbVie Antiretroviral Drug Introduction 11.4.4 AbbVie Revenue in Antiretroviral Drug Business (2016-2021) 11.4.5 AbbVie Recent Development 11.5 Boehringer-Ingelheim 11.5.1 Boehringer-Ingelheim Company Details 11.5.2 Boehringer-Ingelheim Business Overview 11.5.3 Boehringer-Ingelheim Antiretroviral Drug Introduction 11.5.4 Boehringer-Ingelheim Revenue in Antiretroviral Drug Business (2016-2021) 11.5.5 Boehringer-Ingelheim Recent Development 11.6 Johnson and Johnson 11.6.1 Johnson and Johnson Company Details 11.6.2 Johnson and Johnson Business Overview 11.6.3 Johnson and Johnson Antiretroviral Drug Introduction 11.6.4 Johnson and Johnson Revenue in Antiretroviral Drug Business (2016-2021) 11.6.5 Johnson and Johnson Recent Development 11.7 Merck 11.7.1 Merck Company Details 11.7.2 Merck Business Overview 11.7.3 Merck Antiretroviral Drug Introduction 11.7.4 Merck Revenue in Antiretroviral Drug Business (2016-2021) 11.7.5 Merck Recent Development 11.8 CIPLA 11.8.1 CIPLA Company Details 11.8.2 CIPLA Business Overview 11.8.3 CIPLA Antiretroviral Drug Introduction 11.8.4 CIPLA Revenue in Antiretroviral Drug Business (2016-2021) 11.8.5 CIPLA Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Antiretroviral Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Multi-Class Drugs Combination Table 3. Key Players of NRTI Table 4. Key Players of NNRTI Table 5. Key Players of Protease Inhibitors Table 6. Key Players of Other Table 7. Global Antiretroviral Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Antiretroviral Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Antiretroviral Drug Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Antiretroviral Drug Market Share by Regions (2016-2021) Table 11. Global Antiretroviral Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Antiretroviral Drug Market Share by Regions (2022-2027) Table 13. Antiretroviral Drug Market Trends Table 14. Antiretroviral Drug Market Drivers Table 15. Antiretroviral Drug Market Challenges Table 16. Antiretroviral Drug Market Restraints Table 17. Global Antiretroviral Drug Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Antiretroviral Drug Market Share by Players (2016-2021) Table 19. Global Top Antiretroviral Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiretroviral Drug as of 2020) Table 20. Ranking of Global Top Antiretroviral Drug Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Antiretroviral Drug Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Antiretroviral Drug Product Solution and Service Table 24. Date of Enter into Antiretroviral Drug Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Antiretroviral Drug Market Size by Type (2016-2021) (US$ Million) Table 27. Global Antiretroviral Drug Revenue Market Share by Type (2016-2021) Table 28. Global Antiretroviral Drug Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Antiretroviral Drug Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Antiretroviral Drug Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Antiretroviral Drug Revenue Market Share by Application (2016-2021) Table 32. Global Antiretroviral Drug Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Antiretroviral Drug Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Antiretroviral Drug Market Size by Type (2016-2021) (US$ Million) Table 35. North America Antiretroviral Drug Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Antiretroviral Drug Market Size by Application (2016-2021) (US$ Million) Table 37. North America Antiretroviral Drug Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Antiretroviral Drug Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Antiretroviral Drug Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Antiretroviral Drug Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Antiretroviral Drug Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Antiretroviral Drug Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Antiretroviral Drug Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Antiretroviral Drug Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Antiretroviral Drug Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Antiretroviral Drug Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Antiretroviral Drug Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Antiretroviral Drug Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Antiretroviral Drug Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Antiretroviral Drug Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Antiretroviral Drug Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Antiretroviral Drug Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Antiretroviral Drug Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Antiretroviral Drug Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Antiretroviral Drug Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Antiretroviral Drug Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Antiretroviral Drug Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Antiretroviral Drug Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Antiretroviral Drug Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Antiretroviral Drug Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Antiretroviral Drug Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Antiretroviral Drug Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Antiretroviral Drug Market Size by Country (2022-2027) & (US$ Million) Table 64. Gilead Sciences Company Details Table 65. Gilead Sciences Business Overview Table 66. Gilead Sciences Antiretroviral Drug Product Table 67. Gilead Sciences Revenue in Antiretroviral Drug Business (2016-2021) & (US$ Million) Table 68. Gilead Sciences Recent Development Table 69. ViiV Healthcare Company Details Table 70. ViiV Healthcare Business Overview Table 71. ViiV Healthcare Antiretroviral Drug Product Table 72. ViiV Healthcare Revenue in Antiretroviral Drug Business (2016-2021) & (US$ Million) Table 73. ViiV Healthcare Recent Development Table 74. Bristol-Myer Squibb Company Details Table 75. Bristol-Myer Squibb Business Overview Table 76. Bristol-Myer Squibb Antiretroviral Drug Product Table 77. Bristol-Myer Squibb Revenue in Antiretroviral Drug Business (2016-2021) & (US$ Million) Table 78. Bristol-Myer Squibb Recent Development Table 79. AbbVie Company Details Table 80. AbbVie Business Overview Table 81. AbbVie Antiretroviral Drug Product Table 82. AbbVie Revenue in Antiretroviral Drug Business (2016-2021) & (US$ Million) Table 83. AbbVie Recent Development Table 84. Boehringer-Ingelheim Company Details Table 85. Boehringer-Ingelheim Business Overview Table 86. Boehringer-Ingelheim Antiretroviral Drug Product Table 87. Boehringer-Ingelheim Revenue in Antiretroviral Drug Business (2016-2021) & (US$ Million) Table 88. Boehringer-Ingelheim Recent Development Table 89. Johnson and Johnson Company Details Table 90. Johnson and Johnson Business Overview Table 91. Johnson and Johnson Antiretroviral Drug Product Table 92. Johnson and Johnson Revenue in Antiretroviral Drug Business (2016-2021) & (US$ Million) Table 93. Johnson and Johnson Recent Development Table 94. Merck Company Details Table 95. Merck Business Overview Table 96. Merck Antiretroviral Drug Product Table 97. Merck Revenue in Antiretroviral Drug Business (2016-2021) & (US$ Million) Table 98. Merck Recent Development Table 99. CIPLA Company Details Table 100. CIPLA Business Overview Table 101. CIPLA Revenue in Antiretroviral Drug Business (2016-2021) & (US$ Million) Table 102. CIPLA Recent Development Table 103. Research Programs/Design for This Report Table 104. Key Data Information from Secondary Sources Table 105. Key Data Information from Primary Sources List of Figures Figure 1. Global Antiretroviral Drug Market Share by Type: 2020 VS 2027 Figure 2. Multi-Class Drugs Combination Features Figure 3. NRTI Features Figure 4. NNRTI Features Figure 5. Protease Inhibitors Features Figure 6. Other Features Figure 7. Global Antiretroviral Drug Market Share by Application: 2020 VS 2027 Figure 8. Hospital Case Studies Figure 9. Pharmaceutical Companies Case Studies Figure 10. Other Case Studies Figure 11. Antiretroviral Drug Report Years Considered Figure 12. Global Antiretroviral Drug Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Antiretroviral Drug Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Antiretroviral Drug Market Share by Regions: 2020 VS 2027 Figure 15. Global Antiretroviral Drug Market Share by Regions (2022-2027) Figure 16. Global Antiretroviral Drug Market Share by Players in 2020 Figure 17. Global Top Antiretroviral Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiretroviral Drug as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Antiretroviral Drug Revenue in 2020 Figure 19. Global Antiretroviral Drug Revenue Market Share by Type (2016-2021) Figure 20. Global Antiretroviral Drug Revenue Market Share by Type (2022-2027) Figure 21. North America Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Antiretroviral Drug Market Share by Type (2016-2027) Figure 23. North America Antiretroviral Drug Market Share by Application (2016-2027) Figure 24. North America Antiretroviral Drug Market Share by Country (2016-2027) Figure 25. United States Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Antiretroviral Drug Market Share by Type (2016-2027) Figure 29. Europe Antiretroviral Drug Market Share by Application (2016-2027) Figure 30. Europe Antiretroviral Drug Market Share by Country (2016-2027) Figure 31. Germany Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Antiretroviral Drug Market Share by Type (2016-2027) Figure 39. Asia-Pacific Antiretroviral Drug Market Share by Application (2016-2027) Figure 40. Asia-Pacific Antiretroviral Drug Market Share by Region (2016-2027) Figure 41. China Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Antiretroviral Drug Market Share by Type (2016-2027) Figure 49. Latin America Antiretroviral Drug Market Share by Application (2016-2027) Figure 50. Latin America Antiretroviral Drug Market Share by Country (2016-2027) Figure 51. Mexico Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Antiretroviral Drug Market Share by Type (2016-2027) Figure 55. Middle East & Africa Antiretroviral Drug Market Share by Application (2016-2027) Figure 56. Middle East & Africa Antiretroviral Drug Market Share by Country (2016-2027) Figure 57. Turkey Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Antiretroviral Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Gilead Sciences Revenue Growth Rate in Antiretroviral Drug Business (2016-2021) Figure 61. ViiV Healthcare Revenue Growth Rate in Antiretroviral Drug Business (2016-2021) Figure 62. Bristol-Myer Squibb Revenue Growth Rate in Antiretroviral Drug Business (2016-2021) Figure 63. AbbVie Revenue Growth Rate in Antiretroviral Drug Business (2016-2021) Figure 64. Boehringer-Ingelheim Revenue Growth Rate in Antiretroviral Drug Business (2016-2021) Figure 65. Johnson and Johnson Revenue Growth Rate in Antiretroviral Drug Business (2016-2021) Figure 66. Merck Revenue Growth Rate in Antiretroviral Drug Business (2016-2021) Figure 67. CIPLA Revenue Growth Rate in Antiretroviral Drug Business (2016-2021) Figure 68. Bottom-up and Top-down Approaches for This Report Figure 69. Data Triangulation Figure 70. Key Executives Interviewed

Gilead Sciences ViiV Healthcare Bristol-Myer Squibb AbbVie Boehringer-Ingelheim Johnson and Johnson Merck CIPLA